Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 2"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Respiratory+Distress+Syndrome%2C+Newborn%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22
/vufind/Search/Results?lookfor=%22Respiratory+Distress+Syndrome%2C+Newborn%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22
Search /vufind/Search2/Results?lookfor=%22Respiratory+Distress+Syndrome%2C+Newborn%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22
PubPharm (118)
1
A Study of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS) : A Phase 2, Two-Part Study to Evaluate the Safety and Tolerability of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Add-on Reparixin in Adult Patients With ARDS : Phase 2, Randomized, Double-blinded, Placebo-controlled, Multicenter Study to Assess Efficacy and Safety of Reparixin as add-on Therapy to SoC in Acute Respiratory Distress Syndrome (RESPIRATIO)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
A Phase 2b Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study, Evaluating Efficacy and Safety of Allocetra-OTS in Patients With Severe or Critical COVID-19 With Associated Acute Respiratory Distress Syndrome (ARDS) : A Phase 2b Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study, Evaluating Efficacy and Safety of Allocetra-OTS in Patients With Severe or Critical COVID-19 With Associated Acute Respiratory Distress Syndrome (ARDS)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
MRG-001 as an Immunoregulatory and Regenerative Therapy for ARDS Patients : A Phase IIa, Double-Blind, Randomized, Multi-Center Study Comparing MRG-001 to Placebo in Patients With Acute Respiratory Distress Syndrome
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Add-on Reparixin in Adult Patients With ARDS : Phase 2, Randomized, Double-blinded, Placebo-controlled, Multicenter Study to Assess Efficacy and Safety of Reparixin as add-on Therapy to SoC in Acute Respiratory Distress Syndrome (RESPIRATIO)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS) : A Phase 2 Randomized Double-blind Placebo-controlled Study To Evaluate The Efficacy And Safety Of Adjunctive Recombinant Human Plasma Gelsolin With Standard Care For Moderate-to-Severe ARDS Due To Pneumonia Or Other Infections
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
A Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AeroFact : A Partially Blinded, Randomized, Controlled, Parallel-Group, Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AeroFact in Preterm Infants at Risk of Worsening Respiratory Distress Syndrome
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Efficacy and Safety Study of HLCM051(MultiStem®) for Pneumonic Acute Respiratory Distress Syndrome : An Open-label, Standard Therapy as a Controlled, Multicenter Phase 2 Study to Evaluate the Efficacy and Safety of HLCM051(MultiStem) in Patients With Acute Respiratory Distress Syndrome (ARDS) Caused by Pneumonitis
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Study of Safety and Efficacy of ALT-100mAb in Participants With Moderate/Severe ARDS : PUERTA: A P2A Multi-center, Randomized, Double-blind, Placebo-controlled Study Assessing Safety and Efficacy of the eNAMPT Targeting mAb ALT-100 in Moderate/Severe ARDS/VILI Patients
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19) : Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof of Concept Study of LSALT Peptide as Prevention of Acute Respiratory Distress Syndrome (ARDS) and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Phase: Phase 2
Medienart
118
Aufsätze
118
E-Artikel
118
E-Ressourcen
Zeitschriftentitel
118
ClinicalTrials.gov
Thema
118
610
Phase: Phase 2
118
Respiratory Distress Syndrome, Newborn
118
Study Type: Interventional
96
Acute Lung Injury
66
Syndrome
64
Respiratory Distress Syndrome, Adult
54
Respiratory Distress Syndrome
41
Recruitment Status: Completed
28
COVID-19
25
Recruitment Status: Terminated
18
Lung Injury
14
Recruitment Status: Withdrawn
12
Recruitment Status: Recruiting
12
Respiratory Insufficiency
11
Recruitment Status: Not yet recruiting
10
Medical Condition: Acute Respiratory Distress S...
9
Coronavirus Infections
9
Recruitment Status: Unknown status
8
Wounds and Injuries
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
76
2020-
39
2010-2019
3
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
118
Englisch
Haven't found what you're looking for?
Wird geladen...